Exogenous cysteamine increases basal pancreatic exocrine secretion in the rat

Hong Sik Lee, Kwang Hee Kim, Chang Duck Kim, Chi Wook Song, Ho Sang Ryu, Jin Hai Hyun

Research output: Contribution to journalArticle

Abstract

To determine whether exocrine pancreatic secretion is regulated by endogenous somatostatin, somatostatin deficiency was induced by cysteamine. Rats were subcutaneously administered a single dose of cysteamine (30 mg/100 g body weight) 12 hr before experiment. Anesthetized rats were prepared with cannulation into bile duct, pancreatic duct, duodenum, and jugular vein and pancreatic juice was collected. For in vitro study, isolated pancreata of rats, pretreated with cysteamine, were perfused with an intraarterial infusion of Krebs-Henseleit solution (37°C) at 1.2 mL/min, and pancreatic juice was collected in 15-min samples. In vivo experiment of the rat, the mean basal pancreatic secretions, including volume, bicarbonate, and protein output were significantly increased from 18.4±0.5 μL/30 min, 0.58±0.05 μEq/30 min, and 214.0±26.1 μg/30 min to 51.6±3.7 μL/30 min, 1.52±0.11 μEq/30 min, and 569.8±128.9 μg/30 min, respectively (p<0.05). In the isolated perfused pancreas, cysteamine also resulted in a significant increase in basal pancreatic secretion (p<0.05). Simultaneous intraarterial infusion of octreotide (10 pmol/hr) to isolated pancreata partially reversed the effect of cysteamine on basal pancreatic secretion. These findings suggest that endogenous somatostatin play an important role on the regulation of basal pancreatic exocrine secretion.

Original languageEnglish
Pages (from-to)52-56
Number of pages5
JournalJournal of Korean Medical Science
Volume14
Issue number1
Publication statusPublished - 1999 Feb 1

Fingerprint

Cysteamine
Somatostatin
Pancreatic Juice
Pancreas
Intra Arterial Infusions
Octreotide
Pancreatic Ducts
Jugular Veins
Bicarbonates
Bile Ducts
Duodenum
Catheterization
Body Weight
Proteins

Keywords

  • Cysteamine
  • Pancreatic function tests
  • Rats
  • Somatostatin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lee, H. S., Kim, K. H., Kim, C. D., Song, C. W., Ryu, H. S., & Hyun, J. H. (1999). Exogenous cysteamine increases basal pancreatic exocrine secretion in the rat. Journal of Korean Medical Science, 14(1), 52-56.

Exogenous cysteamine increases basal pancreatic exocrine secretion in the rat. / Lee, Hong Sik; Kim, Kwang Hee; Kim, Chang Duck; Song, Chi Wook; Ryu, Ho Sang; Hyun, Jin Hai.

In: Journal of Korean Medical Science, Vol. 14, No. 1, 01.02.1999, p. 52-56.

Research output: Contribution to journalArticle

Lee, HS, Kim, KH, Kim, CD, Song, CW, Ryu, HS & Hyun, JH 1999, 'Exogenous cysteamine increases basal pancreatic exocrine secretion in the rat', Journal of Korean Medical Science, vol. 14, no. 1, pp. 52-56.
Lee, Hong Sik ; Kim, Kwang Hee ; Kim, Chang Duck ; Song, Chi Wook ; Ryu, Ho Sang ; Hyun, Jin Hai. / Exogenous cysteamine increases basal pancreatic exocrine secretion in the rat. In: Journal of Korean Medical Science. 1999 ; Vol. 14, No. 1. pp. 52-56.
@article{3597f95dc55b4fb285fef03eb28966ed,
title = "Exogenous cysteamine increases basal pancreatic exocrine secretion in the rat",
abstract = "To determine whether exocrine pancreatic secretion is regulated by endogenous somatostatin, somatostatin deficiency was induced by cysteamine. Rats were subcutaneously administered a single dose of cysteamine (30 mg/100 g body weight) 12 hr before experiment. Anesthetized rats were prepared with cannulation into bile duct, pancreatic duct, duodenum, and jugular vein and pancreatic juice was collected. For in vitro study, isolated pancreata of rats, pretreated with cysteamine, were perfused with an intraarterial infusion of Krebs-Henseleit solution (37°C) at 1.2 mL/min, and pancreatic juice was collected in 15-min samples. In vivo experiment of the rat, the mean basal pancreatic secretions, including volume, bicarbonate, and protein output were significantly increased from 18.4±0.5 μL/30 min, 0.58±0.05 μEq/30 min, and 214.0±26.1 μg/30 min to 51.6±3.7 μL/30 min, 1.52±0.11 μEq/30 min, and 569.8±128.9 μg/30 min, respectively (p<0.05). In the isolated perfused pancreas, cysteamine also resulted in a significant increase in basal pancreatic secretion (p<0.05). Simultaneous intraarterial infusion of octreotide (10 pmol/hr) to isolated pancreata partially reversed the effect of cysteamine on basal pancreatic secretion. These findings suggest that endogenous somatostatin play an important role on the regulation of basal pancreatic exocrine secretion.",
keywords = "Cysteamine, Pancreatic function tests, Rats, Somatostatin",
author = "Lee, {Hong Sik} and Kim, {Kwang Hee} and Kim, {Chang Duck} and Song, {Chi Wook} and Ryu, {Ho Sang} and Hyun, {Jin Hai}",
year = "1999",
month = "2",
day = "1",
language = "English",
volume = "14",
pages = "52--56",
journal = "Journal of Korean Medical Science",
issn = "1011-8934",
publisher = "Korean Academy of Medical Science",
number = "1",

}

TY - JOUR

T1 - Exogenous cysteamine increases basal pancreatic exocrine secretion in the rat

AU - Lee, Hong Sik

AU - Kim, Kwang Hee

AU - Kim, Chang Duck

AU - Song, Chi Wook

AU - Ryu, Ho Sang

AU - Hyun, Jin Hai

PY - 1999/2/1

Y1 - 1999/2/1

N2 - To determine whether exocrine pancreatic secretion is regulated by endogenous somatostatin, somatostatin deficiency was induced by cysteamine. Rats were subcutaneously administered a single dose of cysteamine (30 mg/100 g body weight) 12 hr before experiment. Anesthetized rats were prepared with cannulation into bile duct, pancreatic duct, duodenum, and jugular vein and pancreatic juice was collected. For in vitro study, isolated pancreata of rats, pretreated with cysteamine, were perfused with an intraarterial infusion of Krebs-Henseleit solution (37°C) at 1.2 mL/min, and pancreatic juice was collected in 15-min samples. In vivo experiment of the rat, the mean basal pancreatic secretions, including volume, bicarbonate, and protein output were significantly increased from 18.4±0.5 μL/30 min, 0.58±0.05 μEq/30 min, and 214.0±26.1 μg/30 min to 51.6±3.7 μL/30 min, 1.52±0.11 μEq/30 min, and 569.8±128.9 μg/30 min, respectively (p<0.05). In the isolated perfused pancreas, cysteamine also resulted in a significant increase in basal pancreatic secretion (p<0.05). Simultaneous intraarterial infusion of octreotide (10 pmol/hr) to isolated pancreata partially reversed the effect of cysteamine on basal pancreatic secretion. These findings suggest that endogenous somatostatin play an important role on the regulation of basal pancreatic exocrine secretion.

AB - To determine whether exocrine pancreatic secretion is regulated by endogenous somatostatin, somatostatin deficiency was induced by cysteamine. Rats were subcutaneously administered a single dose of cysteamine (30 mg/100 g body weight) 12 hr before experiment. Anesthetized rats were prepared with cannulation into bile duct, pancreatic duct, duodenum, and jugular vein and pancreatic juice was collected. For in vitro study, isolated pancreata of rats, pretreated with cysteamine, were perfused with an intraarterial infusion of Krebs-Henseleit solution (37°C) at 1.2 mL/min, and pancreatic juice was collected in 15-min samples. In vivo experiment of the rat, the mean basal pancreatic secretions, including volume, bicarbonate, and protein output were significantly increased from 18.4±0.5 μL/30 min, 0.58±0.05 μEq/30 min, and 214.0±26.1 μg/30 min to 51.6±3.7 μL/30 min, 1.52±0.11 μEq/30 min, and 569.8±128.9 μg/30 min, respectively (p<0.05). In the isolated perfused pancreas, cysteamine also resulted in a significant increase in basal pancreatic secretion (p<0.05). Simultaneous intraarterial infusion of octreotide (10 pmol/hr) to isolated pancreata partially reversed the effect of cysteamine on basal pancreatic secretion. These findings suggest that endogenous somatostatin play an important role on the regulation of basal pancreatic exocrine secretion.

KW - Cysteamine

KW - Pancreatic function tests

KW - Rats

KW - Somatostatin

UR - http://www.scopus.com/inward/record.url?scp=0033073783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033073783&partnerID=8YFLogxK

M3 - Article

C2 - 10102524

AN - SCOPUS:0033073783

VL - 14

SP - 52

EP - 56

JO - Journal of Korean Medical Science

JF - Journal of Korean Medical Science

SN - 1011-8934

IS - 1

ER -